Baseline demographics
| Baseline characteristics | Complete revascularisation | Incomplete revascularisation | P value |
| n | 37 | 16 | |
| Age, mean (years) | 60.77 | 64.21 | 0.17 |
| Age, >65 (%) | 48 | 51 | 0.94 |
| Male sex (%) | 64.1 | 63.1 | 0.95 |
| Height (cm) | 169.5 | 170.3 | 0.96 |
| Height (kg) | 84.9 | 86.4 | 0.94 |
| Never smoked (%) | 49 | 46.4 | 0.92 |
| Former smoker (%) | 40 | 42.5 | 0.94 |
| Current smoker (%) | 11 | 11.1 | 0.97 |
| Diabetic (%) | 11 | 13.5 | 0.89 |
| Hypertension (%) | 94 | 95.3 | 0.97 |
| Dyslipidaemia (%) | 92.5 | 94 | 0.95 |
| Family history of coronary artery disease (%) | 57 | 58.1 | 0.97 |
| ST-segment elevation myocardial infarction (%) | 34.2 | 39.3 | 0.93 |
| Non-ST-segment elevation acute coronary syndrome (%) | 25.2 | 23.9 | 0.91 |
| Chronic coronary syndrome (%) | 40.6 | 36.8 | 0.86 |
| Left ventricular ejection fraction (%) | 49.7 | 50.1 | 0.91 |
| Beta blocker Rx (no) | 36 | 16 | 0.93 |
| Calcium channel blocker Rx (no) | 0 | 0 | |
| Ivabradine Rx (no) | 3 | 1 | 0.94 |
| Salbutamol Rx (no) | 1 | 0 | 0.93 |
| Procedures implanting zotorolamus eluting stents (no) | 5 | 2 | 0.87 |
| Procedures implanting biolimus eluting stents (no) | 2 | 1 | 0.94 |
| Procedures implanting everolimus eluting stents (no) | 33 | 12 | 0.84 |
| Stents implanted (no) | 1.7 | 1.8 | 0.91 |
| Left main stent PCI (no) | 3 | 1 | 0.94 |
| Left anterior descending PCI (no) | 22 | 7 | 0.90 |
| Left circumflex PCI (no) | 12 | 4 | 0.89 |
| Right coronary artery PCI (no) | 26 | 9 | 0.86 |
| Time from revascularisation to active stand (weeks) | 10.4 | 11.1 | 0.88 |
PCI, percutaneous coronary intervention; Rx, prescription.